E. Leschek et al., SEVERE HEMOLYTIC-DISEASE OF THE NEWBORN CAUSED BY ANTI-GONZALES ANTIBODY, American journal of perinatology, 10(5), 1993, pp. 362-364
We report on a female infant with severe hemolytic disease of the newb
orn (HDN) secondary to anti-Gonzales antibody (anti-Go(a)) necessitati
ng an exchange transfusion within the first day of life. The infant wa
s born to a mother known to be Gonzales-antigen negative and a father
who was Gonzales-antigen positive. The mother had an anti-Go(a) titer
of 1:256 at 35 weeks' gestation. The infant was noted to have jaundice
shortly after birth, with a bilirubin of 17.8 mg/dl (total) and .05 m
g/dl (direct) at 11 hours of life. Coombs' test was positive and cord
cells were Gonzales-antigen positive. Eluate on cord cells demonstrate
d anti-Go(a). Despite aggressive phototherapy, the total bilirubin rea
ched 23.3 mg/dl by 24 hours of age and a double-volume exchange transf
usion was performed. Following the exchange transfusion, phototherapy
was continued for several days. The hemoglobin, which was 19.8 gm/dl a
t 11 hours of age, remained stable through the hospitalization, and no
further transfusions were required. History revealed that two prior p
regnancies resulted in Gonzales-antigen positive infants. The first ch
ild experienced mild jaundice requiring no therapy, and the second chi
ld required phototherapy for prolonged hyperbilirubinemia. Previous re
ported cases of anti-Go(a) suggest that this is not a cause of severe
HDN. However, in view of the current case, it may be prudent to follow
women with anti-Go(a) prenatally with amniotic fluid bilirubin studie
s, serial antibody titers, and fetal hemoglobin levels.